lilly tirzepatide approval FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes FDA Approves Eli Lilly's Obesity

Medicare Traditionally, Medicare has not covered weight loss drugs

Oral Surg Oral Med Oral Pathol 48:244-249, 1979

JAMA Network+3MDPI+3ScienceDirect+3 Why Alzheimers has been called type 3 diabetes For more than a decade, researchers have observed that insulin signaling in the brain is impaired in Alzheimers disease (AD)

Clinical consensus guidance Consensus diagnostic criteria for SANS With the number of cases of SANS predicted to increase with the growth of LDSF by space agencies and commercial space flight, there is a growing need to publish current diagnostic criteria

A 2024 review of over 14,000 participants found the actual incidence of thyroid cancer with semaglutide to be less than 1%, suggesting no clear increased risk

But in reality, the risk is so small it barely registers